Literature DB >> 19442944

Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction.

Tareq Ibrahim1, Markus R Makowski, Antanas Jankauskas, David Maintz, Martin Karch, Sylvia Schachoff, Warren J Manning, Albert Schömig, Markus Schwaiger, Rene M Botnar.   

Abstract

OBJECTIVES: Our aim was to determine whether serial contrast-enhanced cardiac magnetic resonance (CE-CMR) is useful for the characterization of tissue signal changes within the coronary vessel wall in patients after acute myocardial infarction (AMI).
BACKGROUND: Inflammation plays a key role in the development of AMI. CE-CMR of the vessel wall has been found useful for the characterization of inflammatory tissue signal changes in patients with carotid artery stenosis, giant cell arteritis, or Takayasu's arteritis; however, it has never been serially performed in the coronary artery wall in patients with acute and chronic myocardial infarction using a gadolinium-based contrast medium and compared with systemic markers of inflammation.
METHODS: CE-CMR using a T1-weighted 3-dimensional gradient echo inversion recovery sequence of the coronary artery wall and 0.2 mmol/kg of gadolinium-diethylenetriaminepentaacetic acid was performed in 10 patients with AMI 6 days and 3 months after coronary intervention and in 9 subjects without coronary artery disease on invasive coronary angiography. Contrast-to-noise ratio (CNR) within the coronary artery wall was quantified in comparison with blood signal.
RESULTS: Patients with AMI demonstrated a significantly increased coronary vessel wall enhancement 6 days after infarction compared with normal subjects (CNR 7.8 +/- 4.4 vs. 5.3 +/- 3.2, p < 0.001). Three months after infarction, CNR decreased to 6.5 +/- 4.7 (p < 0.03). This decrease paralleled declines in C-reactive protein. Angiographically normal segments showed no contrast changes, but CNR significantly decreased in stenotic segments, from 10.9 +/- 3.8 to 6.8 +/- 5.0 (p < 0.002), resulting in a reduction of enhanced segments from 70% to 25% (p < 0.01).
CONCLUSIONS: Serial CE-CMR identified changes in spatial extent and intensity of coronary contrast enhancement in patients after AMI. This technique may be useful for the characterization of transient coronary tissue signal changes, which may represent edema or inflammation during the post-infarction phase. In addition, CE-CMR may offer the potential for visualization of inflammatory activity in atherosclerosis associated with acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442944     DOI: 10.1016/j.jcmg.2008.12.029

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  32 in total

Review 1.  Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography.

Authors:  Veit Sandfort; Joao A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

2.  Noninvasive detection of transplant coronary artery disease with contrast-enhanced cardiac MRI in pediatric cardiac transplants.

Authors:  Mohammad H Madani; Charles E Canter; David T Balzer; Mary P Watkins; Samuel A Wickline
Journal:  J Heart Lung Transplant       Date:  2012-06-29       Impact factor: 10.247

Review 3.  Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  World J Cardiol       Date:  2014-10-26

4.  Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.

Authors:  Ashley F Stein-Merlob; Tetsuya Hara; Jason R McCarthy; Adam Mauskapf; James A Hamilton; Vasilis Ntziachristos; Peter Libby; Farouc A Jaffer
Journal:  Circ Cardiovasc Imaging       Date:  2017-05       Impact factor: 7.792

5.  Atherosclerotic plaque imaging: the last frontier for cardiac magnetic resonance.

Authors:  Christopher M Kramer; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

6.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

7.  Can contrast-enhanced cardiac magnetic resonance assess inflammation of the coronary wall?

Authors:  Debiao Li; Zahi A Fayad; David A Bluemke
Journal:  JACC Cardiovasc Imaging       Date:  2009-05

Review 8.  Quantitative cardiovascular magnetic resonance for molecular imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-03       Impact factor: 5.364

Review 9.  Noninvasive imaging modalities to visualize atherosclerotic plaques.

Authors:  Daisuke Shishikura
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

Review 10.  Imaging of the unstable plaque: how far have we got?

Authors:  Christian M Matter; Matthias Stuber; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2009-10-15       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.